DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > University Hospital > Articles in academic journal >

Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience


File Description SizeFormat
IJH100_464.pdf301.43 kBAdobe PDFView/Open

Title: Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience
Authors: Makiyama, Junya / Imaizumi, Yoshitaka / Tsushima, Hideki / Taniguchi, Hiroaki / Moriwaki, Yuji / Sawayama, Yasushi / Imanishi, Daisuke / Taguchi, Jun / Hata, Tomoko / Tsukasaki, Kunihiro / Miyazaki, Yasushi
Issue Date: Nov-2014
Publisher: 日本血液学会 / Japanese Society of Hematology
Citation: International Journal of Hematology, 100(5), pp.464-472; 2014
Abstract: VCAP (vincristine, cyclophosphamide, doxorubicin, and prednisone)-AMP (doxorubicin, ranimustine, and prednisone)-VECP (vindesine, etoposide, carboplatin, and prednisone) is a standard regimen for aggressive adult T cell leukemia-lymphoma (ATL). However, the efficacy of this regimen has not been fully elucidated for patients aged 70 years or older. Here, we retrospectively analyzed elderly patients with aggressive ATL at Nagasaki University Hospital between 1994 and 2010 to assess treatment outcomes. Of 148 evaluable patients, 54 were aged 70 years or older at diagnosis. The median survival time (MST) and overall survival (OS) at 2 years in elderly patients were 10.6 months and 22.1 %, respectively. Thirty-four patients received VCAP-AMP-VECP as the initial treatment, although the doses were reduced for most patients. In these patients, MST and OS at 2 years were 13.4 months and 26.6 %, respectively. Eleven of 34 patients (32 %) received maintenance oral chemotherapy after two or three cycles of VCAP-AMP-VECP, and MST and OS at 2 years were 16.7 months and 32.7 %, respectively. Our results suggest that the VCAP-AMP-VECP regimen may be effective and that maintenance oral chemotherapy may be considered as a therapeutic option for elderly patients with aggressive ATL.
Keywords: Adult T cell leukemia-lymphoma (ATL) / Chemotherapy / Elderly patients
URI: http://hdl.handle.net/10069/35050
ISSN: 09255710
DOI: 10.1007/s12185-014-1665-0
Rights: © The Japanese Society of Hematology 2014 / The original publication is available at www.springerlink.com
Type: Journal Article
Text Version: author
Appears in Collections:Articles in academic journal

Citable URI : http://hdl.handle.net/10069/35050

All items in NAOSITE are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace